Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes

FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):77-85. doi: 10.1016/S0928-8244(02)00461-3.

Abstract

This investigation was aimed at identifying effective T helper cell epitopes to the hepatitis B virus in humans. A panel of synthetic peptides that represent the hepatitis B virus whole envelope proteins was examined for their capability to stimulate peripheral blood mononuclear cells from human subjects infected with hepatitis B virus naturally. In addition, a large number of subjects were examined and their human leukocyte antigen (HLA) class II allele types were identified to determine whether the helper T cell epitope is specific for a particular HLA allele or 'promiscuous'. The peptides of the amino acid residues 52-67, 110-125, 190-205, and 228-243 appeared to be immunogenic, and particularly, the 52-67 residue was the most promiscuous epitope peptide. These results would contribute to the better understanding of the helper T cell responses to the hepatitis B virus and provide a useful way in designing epitope-based vaccines and future therapeutic strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Epitopes, T-Lymphocyte / immunology*
  • HLA-DQ Antigens / genetics
  • HLA-DR Antigens / genetics
  • Hepatitis B virus / immunology*
  • Histocompatibility Testing
  • Humans
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation
  • Molecular Sequence Data
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Peptides / immunology*
  • T-Lymphocytes, Helper-Inducer / immunology*
  • Vaccines, Synthetic
  • Viral Envelope Proteins / chemistry
  • Viral Envelope Proteins / immunology*

Substances

  • Epitopes, T-Lymphocyte
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • L protein, hepatitis B virus
  • Peptides
  • Vaccines, Synthetic
  • Viral Envelope Proteins